AbbVie (ABBV) Exchange Rate Effect (2013 - 2026)

AbbVie has disclosed Exchange Rate Effect across 14 years of filings, most recently posting -$12.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 233.33% year-over-year to -$12.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 155.26% YoY), while the FY2025 annual figure was $42.0 million, up 164.62% from the prior year.
• Exchange Rate Effect eased to -$12.0 million in Q1 2026, from $11.0 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for ABBV reached as high as $30.0 million in Q2 2025 and fell as low as -$59.0 million in Q3 2022.
• The 5-year median for Exchange Rate Effect is -$8.0 million (2025), against an average of -$5.4 million.
• Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 325.0% — and 2025, when it surged 433.33%.
• A 5-year view of Exchange Rate Effect shows it stood at $23.0 million in 2022, then changed by 0.0% to $23.0 million in 2023, then tumbled by 300.0% to -$46.0 million in 2024, then jumped by 123.91% to $11.0 million in 2025, then slumped by 209.09% to -$12.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$12.0 million, $11.0 million, and -$8.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.